SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. Carey, M. Bruce, M. Horner, Y. Zen, L. D'Antiga, S. Bansal, D. Vergani, G. Mieli-Vergani, HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy, Journal of Viral Hepatitis, 2015, 22, 4
  2. 2
    Chien-Hung Chen, Sheng-Nan Lu, Chuan-Mo Lee, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion, Hepatology International, 2014, 8, 3, 365

    CrossRef

  3. 3
    Tai-Chung Tseng, Jia-Horng Kao, Ding-Shinn Chen, Peginterferon α in the treatment of chronic hepatitis B, Expert Opinion on Biological Therapy, 2014, 14, 7, 995

    CrossRef

  4. 4
    W. P. Brouwer, M. J. Sonneveld, F. Tabak, K. Simon, Y. Cakaloglu, U. S. Akarca, S. Zeuzem, P. Ferenci, J. E. Heathcote, R. J. Knegt, A. Boonstra, B. E. Hansen, H. L. A. Janssen, Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2014, 40, 7
  5. 5
    Milan J. Sonneveld, Willem P. Brouwer, Harry L. A. Janssen, Response-guided Peginterferon Therapy for HBeAg-positive and HBeAg-negative Chronic Hepatitis B using Hepatitis B Surface Antigen Levels: A Review, Current Hepatology Reports, 2014, 13, 3, 250

    CrossRef

  6. 6
    Rama Kapoor, Shyam Kottilil, Strategies to eliminate HBV infection, Future Virology, 2014, 9, 6, 565

    CrossRef

  7. 7
    M. J. Sonneveld, R. Zoutendijk, H. J. Flink, L. Zwang, B. E. Hansen, H. L. A. Janssen, Close Monitoring of Hepatitis B Surface Antigen Levels Helps Classify Flares During Peginterferon Therapy and Predicts Treatment Response, Clinical Infectious Diseases, 2013, 56, 1, 100

    CrossRef

  8. 8
    Milan J. Sonneveld, Vincent Rijckborst, Louwerens Zwang, Stefan Zeuzem, E. Jenny Heathcote, Krzysztof Simon, Roeland Zoutendijk, Ulus S. Akarca, Suzan D. Pas, Bettina E. Hansen, Harry L.A. Janssen, Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants, Antiviral Research, 2013, 97, 3, 312

    CrossRef

  9. 9
    Chih-Lin Lin, Jia-Horng Kao, Hepatitis B viral factors and treatment responses in chronic hepatitis B, Journal of the Formosan Medical Association, 2013, 112, 6, 302

    CrossRef

  10. You have free access to this content10
    Pauline Arends, Milan J. Sonneveld, Harry L. A. Janssen, Hepatitis B virus treatment: Which patients should be treated with interferon?, Clinical Liver Disease, 2013, 2, 1
  11. 11
    Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, Pietro Lampertico, Massimo Colombo, PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history, Expert Review of Anti-infective Therapy, 2013, 11, 5, 459

    CrossRef

  12. 12
    P. Arends, H. L. A. Janssen, Response Guided Treatment for Peginterferon in Chronic Hepatitis B, Current Hepatitis Reports, 2013, 12, 2, 88

    CrossRef

  13. 13
    Milan J. Sonneveld, Bettina E. Hansen, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Qing Xie, E. Jenny Heathcote, Henry L.-Y. Chan, Harry L.A. Janssen, Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels, Hepatology, 2013, 58, 3
  14. 14
    Mauro Viganò, Giampaolo Mangia, Pietro Lampertico, Results of Treatment of Chronic Hepatitis B with Pegylated Interferon, Clinics in Liver Disease, 2013, 17, 3, 425

    CrossRef

  15. 15
    Milan J. Sonneveld, Pauline Arends, Andre Boonstra, Bettina E. Hansen, Harry L.A. Janssen, Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B, Journal of Hepatology, 2013, 58, 5, 898

    CrossRef

  16. 16
    Stephanos J. Hadziyannis, Dimitrios Vassilopoulos, Emilia Hadziyannis, Antiviral Agents, 2013,

    CrossRef